Profil
Christopher Hwang is currently Head-Global Partnerships at Transcenta Holding Ltd. since 2026, with employment at the firm starting in 2016.
Formerly, Dr. Hwang was Senior Director at Genzyme Corp.
from 2005 to 2016 and Senior Director at Sanofi from 2005 to 2016.
Education includes an undergraduate degree conferred in 1985 and a doctorate conferred in 1992, both from the Massachusetts Institute of Technology.
Postes actifs de Christopher Hwang
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Corporate Officer/Principal | 30/03/2026 |
Anciens postes connus de Christopher Hwang
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Directeur/Membre du Conseil | 01/09/2016 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Directeur/Membre du Conseil | 01/02/2016 |
Formation de Christopher Hwang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Transcenta Holding Ltd.
Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products | Health Technology |
















